Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naazish S Bashir

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Genome|December 2, 2015
The 3-I framework: a framework for developing public policies regarding pharmacogenomics (PGx) testing in CanadaNaazish S Bashir, Wendy J Ungar
Journal of Community Genetics|February 16, 2022
Considerations for developing regulations for direct-to-consumer genetic testing: a scoping review using the 3-I frameworkAlexandra Cernat, Naazish S Bashir, Wendy J Ungar
MDM Policy & Practice|March 2, 2023
Infliximab Pricing in International Economic Evaluations in Inflammatory Bowel Disease to Inform Biologic and Biosimilar Access Policies: A Systematic ReviewNaazish S Bashir, Avery Hughes, Wendy J Ungar
Children (Basel, Switzerland)|April 30, 2021
An Assessment of the Validity and Reliability of the Pediatric Child Health Utility 9D in Children with Inflammatory Bowel DiseaseNaazish S Bashir, Thomas D Walters, Anne M Griffiths, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|May 27, 2021
Imputing missing patient-level data and propensity score matching in cost-effectiveness analysis in Crohn's diseaseNaazish S Bashir, Thomas D Walters, Anne M Griffiths, et al.
Inflammatory Bowel Diseases|November 16, 2019
Cost-effectiveness and Clinical Outcomes of Early Anti-Tumor Necrosis Factor-α Intervention in Pediatric Crohn's DiseaseNaazish S Bashir, Thomas D Walters, Anne M Griffiths, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 2, 2023
A comparison of the Child Health Utility 9D and the Health Utilities Index for estimating health utilities in pediatric inflammatory bowel diseaseNaazish S Bashir, Thomas D Walters, Anne M Griffiths, et al.
Journal of the Canadian Association of Gastroenterology|April 7, 2023
A Comparison of Preference-Based, Generic and Disease-Specific Health-Related Quality of Life in Pediatric Inflammatory Bowel DiseaseNaazish S Bashir, Thomas D Walters, Anne M Griffiths, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 15, 2021
The Clinician-reported Genetic testing Utility InDEx (C-GUIDE): Preliminary evidence of validity and reliabilityRobin Z Hayeems, Stephanie Luca, Wendy J Ungar, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Genome|December 2, 2015
The 3-I framework: a framework for developing public policies regarding pharmacogenomics (PGx) testing in CanadaNaazish S Bashir, Wendy J Ungar
Journal of Community Genetics|February 16, 2022
Considerations for developing regulations for direct-to-consumer genetic testing: a scoping review using the 3-I frameworkAlexandra Cernat, Naazish S Bashir, Wendy J Ungar
MDM Policy & Practice|March 2, 2023
Infliximab Pricing in International Economic Evaluations in Inflammatory Bowel Disease to Inform Biologic and Biosimilar Access Policies: A Systematic ReviewNaazish S Bashir, Avery Hughes, Wendy J Ungar
Children (Basel, Switzerland)|April 30, 2021
An Assessment of the Validity and Reliability of the Pediatric Child Health Utility 9D in Children with Inflammatory Bowel DiseaseNaazish S Bashir, Thomas D Walters, Anne M Griffiths, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|May 27, 2021
Imputing missing patient-level data and propensity score matching in cost-effectiveness analysis in Crohn's diseaseNaazish S Bashir, Thomas D Walters, Anne M Griffiths, et al.
Inflammatory Bowel Diseases|November 16, 2019
Cost-effectiveness and Clinical Outcomes of Early Anti-Tumor Necrosis Factor-α Intervention in Pediatric Crohn's DiseaseNaazish S Bashir, Thomas D Walters, Anne M Griffiths, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 2, 2023
A comparison of the Child Health Utility 9D and the Health Utilities Index for estimating health utilities in pediatric inflammatory bowel diseaseNaazish S Bashir, Thomas D Walters, Anne M Griffiths, et al.
Journal of the Canadian Association of Gastroenterology|April 7, 2023
A Comparison of Preference-Based, Generic and Disease-Specific Health-Related Quality of Life in Pediatric Inflammatory Bowel DiseaseNaazish S Bashir, Thomas D Walters, Anne M Griffiths, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 15, 2021
The Clinician-reported Genetic testing Utility InDEx (C-GUIDE): Preliminary evidence of validity and reliabilityRobin Z Hayeems, Stephanie Luca, Wendy J Ungar, et al.
Pageof 1